Onderneming Protagenic Therapeutics, Inc. Other OTC
Aandelen
PTIX
US74365N1037
Biotechnologie & Medisch Onderzoek
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Alexander Arrow
DFI | Director of Finance/CFO | 53 | 01-02-16 |
Andrew Slee
COO | Chief Operating Officer | 74 | 01-04-16 |
Robert Stein
CTO | Chief Tech/Sci/R&D Officer | 73 | 12-02-16 |
Corporate Officer/Principal | - | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Garo Armen
FOU | Founder | 71 | 03-02-94 |
Robert Stein
CTO | Chief Tech/Sci/R&D Officer | 73 | 12-02-16 |
Brian Corvese
BRD | Director/Board Member | 67 | 28-07-17 |
Khalil Barrage
BRD | Director/Board Member | 59 | 01-07-07 |
Timothy Wright
BRD | Director/Board Member | 66 | 23-11-22 |
Jennifer Buell
BRD | Director/Board Member | 50 | 18-07-20 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 4 435 132 | 3 466 915 ( 78,17 %) | 0 | 78,17 % |
Bedrijfsgegevens
Protagenic Therapeutics, Inc.
149 Fifth Avenue Suite 500
10010, New York
+212 994 8200
http://www.protagenic.comSector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+40,80% | 53,67 mld. | |
+35,79% | 38,86 mld. | |
-8,05% | 38,76 mld. | |
-8,98% | 27,27 mld. | |
+10,69% | 25,91 mld. | |
-16,21% | 20,29 mld. | |
+31,00% | 12,78 mld. | |
+28,51% | 12,18 mld. | |
-1,67% | 11,96 mld. |